Subscribe
Data & Research
4 min read

Europe's First Full D2C Pet Food Map Counts 113 Brands and One Company That Took Half the Money

A new benchmark called the D2C Pet Food Landscape 2026 maps 113 European direct-to-consumer pet food brands across 28 countries, finding 811M euros raised but extreme concentration: 61% of brands raised nothing and one company took more than half. The report also flags a 66% subscription rate at a 38% premium and a 48% West-to-East price gap. Its author, Proteine Resources, is itself a market participant.

Written by
The Underbite
Published on
June 25, 2026
Europe's First Full D2C Pet Food Map Counts 113 Brands and One Company That Took Half the Money

Europe's direct-to-consumer pet food market finally has an end-to-end map, and the first thing it shows is how lopsided the money is. A new independent benchmark counts 113 brands across 28 countries that have together pulled in 811 million euros, yet 61 percent of those brands have raised nothing and a single company captured more than half of all disclosed funding. The catch worth flagging up front: the firm that drew the map also sells into the market it measured.

What the map actually found

The benchmark, called the D2C Pet Food Landscape 2026, classifies and price-checks 113 brands by hand across nearly 9,000 products. Roughly 65 percent of those brands were founded since 2015, which frames the category as young and still forming rather than settled.

Two structural findings stand out for anyone selling online. Subscriptions dominate, with 66 percent of brands running a recurring model at roughly a 38 percent premium over one-off purchases. And geography still sets price: the data shows a West-to-East gap of about 48 percent across the continent, a spread the report says is slowly closing as Eastern European brands mature and Western ones expand east.

The report also pushes back on a unit-economics reflex. Measured per kilogram, fresh and raw diets look expensive next to dry food. Measured per day of feeding, the math often flips, because denser or portion-controlled formats change the real cost of feeding an animal. For operators pricing against a dry-kibble anchor, that reframing is the practical takeaway.

Why the funding gap matters to operators

The concentration number is the one to sit with. If 811 million euros has entered the category but more than half went to one company and 61 percent of brands raised nothing, the market is not broadly capitalized. It is a handful of funded players and a long tail competing on cash flow, not venture money. On the report's own numbers, a single British brand, Butternut Box, accounts for roughly 55 percent of all disclosed European funding.

That shapes real decisions. A founder weighing a raise is competing for attention in a category investors may already consider claimed at the top. A retailer or co-manufacturer evaluating partners is mostly looking at brands that have to be capital-efficient by necessity. And an incumbent watching for threats can see that the disruption, so far, is concentrated rather than swarming. The map argues the D2C wave in European pet food is real but narrower at the top than the brand count suggests.

Read the source before you trust the benchmark

The data is useful, and the methodology is disclosed: prices pulled from each brand's own webshop over May and June 2026, verified by hand with AI-assisted tooling, normalized to euro per kilogram, and aggregated by median to limit outlier distortion. Funding reflects publicly disclosed rounds only, which means private or undisclosed capital sits outside the 811 million euro figure.

The disclosure that matters most is about the author. Proteine Resources is not a neutral research house. It makes a functional protein ingredient, runs its own pet food brand, and manufactures private-label ranges for partners across Europe, and it secured roughly 9.5 million euros in EU EIC Accelerator funding to build out production.

A market map is also a positioning document. Publishing the definitive landscape of D2C pet food puts an ingredient and private-label supplier at the center of the conversation its customers are having. The numbers can be sound and the exercise can still be strategic. Operators should use the data and read the framing with that in mind.

Source: Proteine Resources via Webflow press submission (Jun 24, 2026); report at d2c.proteineresources.com; company background and funding via The Recursive; report figures corroborated by Pet Business World and Pet Gazette.

Subscribe to newsletter

Join our newsletter to stay up to date on features and releases.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

What's Happening

Other News

More stories shaping the pet industry this week. From funding rounds and product launches to regulatory shifts and retail strategy, stay ahead of what's driving the market.

Read article
Vetspire Splits From Thrive, Lands a Battery Ventures Backing
Funding & M&A
4 min read

Vetspire Splits From Thrive, Lands a Battery Ventures Backing

Vetspire has spun out of Thrive Pet Healthcare's orbit with a growth investment from Battery Ventures and a new CEO, Zachary Seely. The AI-powered practice management platform, used by more than 800 veterinary hospitals and clinics, will operate independently while Thrive remains a customer. The deal tests whether AI-native vet software can draw institutional capital without a strategic parent underwriting it.

Read article
Read article
PetMeds Revenue Falls 20% as Takeover Fight Drags On
Earnings
6 min read

PetMeds Revenue Falls 20% as Takeover Fight Drags On

PetMeds' first-quarter revenue fell 19.9% to $41.0 million and cash reserves dropped to $13.1 million, even as the company narrowed its net loss to $6.1 million from $34.2 million a year earlier. The results land as an unsolicited $3-a-share buyout offer from SilverCape Investments remains on the table and a $37 million sale-leaseback of its headquarters awaits closing.

Read article
Read article
FDA Clears Zoetis Drug for Screwworm as Outbreak Spreads North
Regulatory
4 min read

FDA Clears Zoetis Drug for Screwworm as Outbreak Spreads North

The FDA granted Zoetis an emergency use authorization for Simparica Trio to treat New World screwworm in dogs, the first product cleared specifically for the threat. Texas has already begun requiring treatment before dogs cross certain lines, putting boarding facilities, transporters, and border-state vet practices under a new compliance mandate.

Read article
View all articles